- Home
- AKRO vs CAMT Comparison
AKRO vs CAMT Comparison
Compare AKRO & CAMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- CAMT
- Stock Information
- Founded
- AKRO 2017
- CAMT 1987
- Country
- AKRO United States
- CAMT Israel
- Employees
- AKRO N/A
- CAMT N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- CAMT Electronic Components
- Sector
- AKRO Health Care
- CAMT Technology
- Exchange
- AKRO Nasdaq
- CAMT Nasdaq
- Market Cap
- AKRO 3.9B
- CAMT 4.1B
- IPO Year
- AKRO 2019
- CAMT 2000
- Fundamental
- Price
- AKRO $50.56
- CAMT $95.81
- Analyst Decision
- AKRO Strong Buy
- CAMT Strong Buy
- Analyst Count
- AKRO 6
- CAMT 11
- Target Price
- AKRO $82.50
- CAMT $91.82
- AVG Volume (30 Days)
- AKRO 1.1M
- CAMT 375.3K
- Earning Date
- AKRO 08-08-2025
- CAMT 08-05-2025
- Dividend Yield
- AKRO N/A
- CAMT 1.39%
- EPS Growth
- AKRO N/A
- CAMT 46.65
- EPS
- AKRO N/A
- CAMT 2.61
- Revenue
- AKRO N/A
- CAMT $450,862,000.00
- Revenue This Year
- AKRO N/A
- CAMT $16.17
- Revenue Next Year
- AKRO N/A
- CAMT $8.71
- P/E Ratio
- AKRO N/A
- CAMT $36.07
- Revenue Growth
- AKRO N/A
- CAMT 32.63
- 52 Week Low
- AKRO $21.34
- CAMT $47.41
- 52 Week High
- AKRO $58.40
- CAMT $110.73
- Technical
- Relative Strength Index (RSI)
- AKRO 44.48
- CAMT 73.42
- Support Level
- AKRO $50.60
- CAMT $92.50
- Resistance Level
- AKRO $52.55
- CAMT $95.37
- Average True Range (ATR)
- AKRO 1.83
- CAMT 3.05
- MACD
- AKRO -0.35
- CAMT -0.09
- Stochastic Oscillator
- AKRO 17.66
- CAMT 85.04
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About CAMT Camtek Ltd.
Camtek Ltd is engaged in the manufacturing of metrology and inspection equipment and software solutions for the semiconductor industry. Its systems inspect wafers for various semiconductor market segments, including Advanced Packaging, Heterogenous Integration (HI), Compound Semiconductors, Memory, and foundries among others. Geographically, it derives maximum revenue from China followed by Asia Pacific, Korea, United States, and Europe. The company's products and services include Surface Inspection, Bump Inspection and Metrology, and others.